Preminent

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
OBJECTIVE Losartan/hydrochlorothiazide (HCTZ) (Preminent®) is a fixed-dose combination of angiotensin II receptor blocker (ARB… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2012
2012
OBJECTIVE Many patients still have high blood pressure (BP) after treatment with high-dose angiotensin II type 1 receptor… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2011
2011
The clinical course of losartan potassium/hydrochlorothiazide (Preminent(®))-induced hyponatremia has not been described. We… Expand
  • table 1
  • table 2
Is this relevant?
2011
2011
OBJECTIVE We analyzed the efficacy and safety of Preminent(®) [losartan (50 mg/day)/HCTZ (12.5 mg/day)] compared to CodioMD… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2008
2008
Hypertension is a critical risk factor for cardiovascular disease that affects an estimated 35 million people in Japan. According… Expand
Is this relevant?
Review
1999
Review
1999
Topotecan, a semi-synthetic derivative of the alkaloid camptothecin is an antitumor drug that like other camptothecin derivatives… Expand
Is this relevant?
Review
1981
Review
1981
More than 300 cases of Delirium Tremens have observed at the Department of Emergency Surgery of the Ospedale Delmati di S. Angelo… Expand
Is this relevant?